p6

Cambridge Healthtech Institute’s 4th Annual

Bioprocess Data Management and Analysis
( バイオプロセスのデータ管理と分析 )

Advancing Bioprocessing Through Instrumentation, Characterization, Control, and Analytics

1月20日~21日

Part of the Process Technologies & Purification pipeline

The biopharmaceutical industry is meeting increasing demands and costs for biotherapeutics through process optimization. Data from advanced instrumentation through sampling techniques, new sensor technologies, and analyzers have emerged to monitor both upstream and downstream processes. When well-prepared and analyzed, this data leads to process knowledge, process control, and continuous improvement, resulting in greater speed, quality, and economy. Cambridge Healthtech Institute’s 4th Annual Bioprocess Data Management and Analysis conference addresses statistical analysis strategies allowing for optimized and informed control of bioprocessing.

Preliminary Agenda

BIOTHERAPEUTIC ENGINEERING AND ANALYTICS

Platformization of Multi-Specific Protein Engineering: Learning from High-Throughput Screening Data
Norbert Furtmann, PhD, Head of Data Lab, High Throughput Biologics, Sanofi-Aventis Deutschland GmbH

E2E Biologics Platform - From Discovery to Development
Yuan Lin, Biologics Solution Lead, Pfizer Inc.

How Can Systems Biology Tools Facilitate a Cost-Effective Upstream Process Development in the Biopharmaceutical Industry?
Anne Richelle, PhD, Senior Specialist - Metabolic Modeling, GSK, Belgium

Quality by Design Revealed That Oxidation of a Recombinant Fab is Driven by CHO Cell Growth Conditions, Physiology, and Over Expression of Oxidative Stress Genes 

Khandaker Siddiquee, PhD, Principal Scientist, Biologic Process Design, Abbott Diagnostic Division, Abbott Laboratories

 



* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。

Choose your language
Traditional Chinese
Simplified Chinese
Korean
English


更新通知サービス




2020年のカンファレンスプログラムと研修セミナー


メール配信サービス